Evaluation of cardiac findings in mucopolysaccharidosis

被引:3
作者
Dehghan, Bahar [1 ]
Rostampour, Noushin [2 ]
Sedighi, Mohsen [3 ]
Saryazdi, Mohammad Hosseini [4 ]
Rizi, Mohammad Jokar [4 ]
Mostofizadeh, Neda [2 ]
Hashemipour, Mahin [2 ]
Khoshhali, Mehri [5 ]
机构
[1] Isfahan Univ Med Sci, Cardiovasc Res Inst, Pediat Cardiovasc Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Metab Liver Dis Res Ctr, Esfahan, Iran
[3] Iran Univ Med Sci, Trauma & Injury Res Ctr, Tehran, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Isfahan Univ Med Sci, Child Growth & Dev Res Ctr, Esfahan, Iran
关键词
Mucopolysaccharidoses; Children; Heart; Echocardiography; ENZYME-REPLACEMENT THERAPY; INVOLVEMENT; MORTALITY; CHILDREN;
D O I
10.1007/s10554-023-02983-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Mucopolysaccharidoses (MPS) are a group of rare genetic diseases and heart involvement is one of the important conflicts in most types, which may cause serious complications. We used M-Mode and two-dimensional speckle tracking echocardiography (2D-STE) to explore cardiovascular involvements in MPS patients.Method The present cross-sectional study investigated the frequency of cardiac involvements in MPS patients. Included participants were MPS types I, II, III, IV, and VI who underwent specialized echocardiography exams to assess valvular function, systolic and diastolic function, left ventricular ejection fraction (LVEF), and global longitudinal strain (GLS).Results 35 patients were enrolled in this study. The total mean age of patients was 9.58 +/- 5.11 years and 71.4% were male. Type IV (40%) and type III (31.4%) were the most frequent MPS. Although LVEF did not differ notably among MPS types, GLS was significantly different (p = 0.029). Mitral regurgitation was observed remarkably more in MPS type III (p = 0.001) while mitral stenosis was more common in type III (p = 0.007). There was a significant association between LVEF and GLS (beta= -0.662; p = 0.025) and between LVEF and MPS type (beta = 1.82; p = 0.025) when adjusted for GLS.Conclusion Cardiac complications are very common and are one of the most important causes of death in MPS patients. 2D-STE seems to be superior to M-Mode for detection of early and subclinical cardiac dysfunction in MPS patients.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 25 条
[1]   Early diagnosis and management of cardiac manifestations in mucopolysaccharidoses: a practical guide for paediatric and adult cardiologists [J].
Boffi, Lucia ;
Russo, Pierluigi ;
Limongelli, Giuseppe .
ITALIAN JOURNAL OF PEDIATRICS, 2018, 44
[2]   Mucopolysaccharidosis: Cardiologic features and effects of enzyme-replacement therapy in 24 children with MPS I, II and VI [J].
Brands, Marion M. M. G. ;
Frohn-Mulder, Ingrid M. ;
Hagemans, Marloes L. C. ;
Hop, Wim C. J. ;
Oussoren, Esmee ;
Helbing, Wim A. ;
van der Ploeg, Ans T. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2013, 36 (02) :227-234
[3]   Cardiac findings after enzyme replacement therapy for mucopolysaccharidosis type I [J].
Braunlin, Elizabeth A. ;
Berry, James M. ;
Whitley, Chester B. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03) :416-418
[4]   Assessment of Cardiac Function in Children by Strain Imaging and its Correlation with Conventional Echocardiographic Parameter [J].
Chatterjee, Suman ;
Mukherjee, Somnath ;
Rani, Neha ;
Kumar, Prashant ;
Kumar, Prakash ;
Sarkar, Achyut .
ANNALS OF CARDIAC ANAESTHESIA, 2022, 25 (03) :264-269
[5]   Cardiovascular changes in mucopolysaccharidoses in Taiwan [J].
Chen, MR ;
Lin, SP ;
Hwang, HK ;
Yu, CH .
ACTA CARDIOLOGICA, 2005, 60 (01) :51-53
[6]   The natural course and the impact of therapies of cardiac involvement in the mucopolysaccharidoses [J].
Fesslova, Vlasta ;
Corti, Paola ;
Sersale, Giovanna ;
Rovelli, Attilio ;
Russo, Pierluigi ;
Mannarino, Savina ;
Butera, Gianfranco ;
Parini, Rossella .
CARDIOLOGY IN THE YOUNG, 2009, 19 (02) :170-178
[7]   Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) [J].
Golda, Adam ;
Jurecka, Agnieszka ;
Tylki-Szymanska, Anna .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 158 (01) :6-11
[8]   Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS) [J].
Jones, S. A. ;
Almassy, Z. ;
Beck, M. ;
Burt, K. ;
Clarke, J. T. ;
Giugliani, R. ;
Hendriksz, C. ;
Kroepfl, T. ;
Lavery, L. ;
Lin, S. -P. ;
Malm, G. ;
Ramaswami, U. ;
Tincheva, R. ;
Wraith, J. E. .
JOURNAL OF INHERITED METABOLIC DISEASE, 2009, 32 (04) :534-543
[9]   Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome) [J].
Kampmann, Christoph ;
Abu-Tair, Tariq ;
Goekce, Seyfullah ;
Lampe, Christina ;
Reinke, Joerg ;
Mengel, Eugen ;
Hennermann, Julia B. ;
Wiethoff, Christiane M. .
PLOS ONE, 2016, 11 (09)
[10]   Home sleep study characteristics in patients with mucopolysaccharidosis [J].
Kasapkara, Cigdem Seher ;
Tumer, Leyla ;
Aslan, Ayse Tana ;
Hasanoglu, Alev ;
Ezgu, Fatih Suheyl ;
Kucukcongar, Aynur ;
Tunca, Zeynep ;
Kokturk, Oguz .
SLEEP AND BREATHING, 2014, 18 (01) :143-149